Stock ZYDUSLIFE ZYDUS LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 06:49:34 2025-01-15 am EST 		5-day change 1st Jan Change
984.90 INR -1.52% Intraday chart for Zydus Lifesciences Limited -1.59% +1.36%
Jan. 10 Nomura Upgrades Zydus Lifesciences to Buy From Neutral, Adjusts Price Target to INR1,140 From INR1,030 MT
Jan. 07 CVS Health Unit to Include Zydus Lifesciences' Diabetes Medications in Template Formulary MT

Evolution of the Average Target: Zydus Lifesciences Limited

average-target-price-chart ZYDUS-LIFESCIENCES-LIMITE

Evolution of the Target Price: Zydus Lifesciences Limited

target-price-consensus-chart ZYDUS-LIFESCIENCES-LIMITE

Changes in Analyst Recommendations: Zydus Lifesciences Limited

0274a4ce.ZzbZn4n9HWFV5Ik_FcwDgxzOnRqWKZsiKkrqo0jTWLk.I3q68vuJU0wvks5yfL1GwlP5zCylWt9tRhmTmnibHs0DUej2xdBoFWW82A~bbc293bb05d91cb5414080df4f7fb56c

Analysts' recommendations: Zydus Lifesciences Limited

Nomura Upgrades Zydus Lifesciences to Buy From Neutral, Adjusts Price Target to INR1,140 From INR1,030 Jan. 10 MT
Nomura Adjusts Zydus Lifesciences' Price Target to INR1,030 From INR1,020, Keeps at Neutral Nov. 14 MT
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,380 From INR1,450, Keeps at Buy Nov. 13 MT
Jefferies Upgrades Zydus Lifesciences to Buy From Hold, Adjusts Price Target to INR1,450 From INR1,210 24-08-28 MT
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,210 From INR1,070, Keeps at Hold 24-08-12 MT
Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988 24-05-21 MT
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold 24-05-20 MT
Jefferies Adjusts Zydus Lifesciences’ Price Target to INR750 From INR660, Keeps at Hold 24-02-12 MT
Jefferies Adjusts Zydus Lifesciences’ Price Target to INR640 From INR630, Keeps at Hold 23-11-08 MT
Nomura Adjusts Zydus Lifesciences' Price Target to INR747 From INR540, Keeps at Buy 23-08-15 MT
Jefferies Downgrades Zydus Lifesciences to Hold From Buy, Adjusts Price Target to INR630 From INR585 23-08-14 MT
Jefferies Adjusts Zydus Lifesciences' Price Target to INR585 From INR575, Keeps at Buy 23-05-19 MT
Nomura Adjusts Zydus Lifesciences' Price Target to INR540 From INR489, Keeps at Buy 23-02-07 MT
Nomura Adjusts Cadila Healthcare's Price Target to 489 Indian Rupees From 481 Indian Rupees, Keeps at Buy 22-02-07 MT
More recommendations

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+7.94%
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+15.74%
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+15.12%
SANDOZ GROUP AG Stock Sandoz Group AG
+14.87%
CIPLA LIMITED Stock Cipla Limited
+13.35%
GLENMARK PHARMACEUTICALS LIMITED Stock Glenmark Pharmaceuticals Limited
+14.88%
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
+25.95%
GEDEON RICHTER Stock Gedeon Richter
+14.07%
Average +15.24%
Weighted average by Cap. +14.86%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
1,000.15INR
Average target price
1,079.53INR
Spread / Average Target
+7.94%
High Price Target
1,380.00INR
Spread / Highest target
+37.98%
Low Price Target
794.00INR
Spread / Lowest Target
-20.61%

Analyst Consensus Detail

consensus-detail-chart ZYDUS-LIFESCIENCES-LIMITE

Consensus revision (last 18 months)

consensus-revision-chart ZYDUS-LIFESCIENCES-LIMITE

Analysts covering the company

Nomura
Jefferies & Co.

Ratings

Trading Rating
Investor Rating
ESG MSCI
BB
surperformance-ratings-light-chart ZYDUS-LIFESCIENCES-LIMITEMore Ratings
Profit revisions
estimates-change-chart ZYDUS-LIFESCIENCES-LIMITE Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart ZYDUS-LIFESCIENCES-LIMITE Company calendar
  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. Consensus Zydus Lifesciences Limited